17921990

Source:http://linkedlifedata.com/resource/pubmed/id/17921990

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013058, umls-concept:C0030650, umls-concept:C0031336, umls-concept:C1332768, umls-concept:C1334325, umls-concept:C1364078, umls-concept:C1553890, umls-concept:C1704803, umls-concept:C1825781
pubmed:issue	10
pubmed:dateCreated	2007-10-8
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9604648
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1087-0156
pubmed:author	pubmed-author:CohenMarkM, pubmed-author:TeitelbaumRachelR
pubmed:issnType	Print
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1105-6
pubmed:meshHeading	pubmed-meshheading:17921990-Biotechnology, pubmed-meshheading:17921990-Drug Industry, pubmed-meshheading:17921990-Legislation, Drug, pubmed-meshheading:17921990-Patents as Topic, pubmed-meshheading:17921990-Supreme Court Decisions, pubmed-meshheading:17921990-United States
pubmed:year	2007
pubmed:articleTitle	Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
pubmed:affiliation	Rachel Teitelbaum and Mark Cohen are at Pearl Cohen Zedek Latzer LLP, 1500 Broadway, 12th Floor, New York, New York 10036, USA. rachelt@pczlaw.com
pubmed:publicationType	Journal Article